Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
- PMID: 599411
- DOI: 10.1007/BF01059688
Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
Similar articles
-
A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.J Pharmacokinet Biopharm. 1986 Jun;14(3):261-88. doi: 10.1007/BF01106707. J Pharmacokinet Biopharm. 1986. PMID: 3783447
-
Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.J Pharm Pharmacol. 1983 Apr;35(4):219-24. doi: 10.1111/j.2042-7158.1983.tb02916.x. J Pharm Pharmacol. 1983. PMID: 6133930
-
Altered hepatic blood flow and drug disposition.Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005. Clin Pharmacokinet. 1976. PMID: 13954 Review.
-
Commentary: a physiological approach to hepatic drug clearance.Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377. Clin Pharmacol Ther. 1975. PMID: 1164821
-
Hepatic clearance measurements and pharmacokinetics.Pharmacology. 1979;19(3):105-10. doi: 10.1159/000137296. Pharmacology. 1979. PMID: 392549 Review.
Cited by
-
A tutorial for model-based evaluation and translation of cardiovascular safety in preclinical trials.CPT Pharmacometrics Syst Pharmacol. 2024 Jan;13(1):5-22. doi: 10.1002/psp4.13082. Epub 2023 Nov 23. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 37950388 Free PMC article.
-
ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.Toxicol Sci. 2023 Oct 30;196(1):1-15. doi: 10.1093/toxsci/kfad081. Toxicol Sci. 2023. PMID: 37584694 Free PMC article.
-
Utility of Minimal Physiologically Based Pharmacokinetic Models for Assessing Fractional Distribution, Oral Absorption, and Series-Compartment Models of Hepatic Clearance.Drug Metab Dispos. 2023 Oct;51(10):1403-1418. doi: 10.1124/dmd.123.001403. Epub 2023 Jul 17. Drug Metab Dispos. 2023. PMID: 37460222
-
A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter fd in Physiologically Based Pharmacokinetics.J Pharm Sci. 2024 Jan;113(1):95-117. doi: 10.1016/j.xphs.2023.05.019. Epub 2023 Jun 4. J Pharm Sci. 2024. PMID: 37279835
-
In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542.Front Pharmacol. 2023 Feb 15;14:1067408. doi: 10.3389/fphar.2023.1067408. eCollection 2023. Front Pharmacol. 2023. PMID: 36874001 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources